BI-RADS 4A Workup and Specialist Type
BI-RADS 4A is a breast imaging assessment category that indicates a suspicious finding. Category 4 findings warrant tissue diagnosis (biopsy) or other specified management rather than management based on gynecologic indications alone. [1], [2], [3], [4]
Why Gynecologic Specialist Evaluation Is Not Required
BI-RADS category 4A is part of a breast imaging reporting system used to communicate the need for breast-focused diagnostic evaluation. The recommended next step is driven by the radiology risk category and the need for breast tissue diagnosis, not by the specialty of the clinician receiving the report. [2], [3]
Core Recommendation for BI-RADS 4A Findings
Tissue diagnosis is recommended for BI-RADS category 4 (including 4A) suspicious lesions requiring diagnosis. [1], [5]
Medication- and Procedure-Related Decision Framework
Evaluation is driven by the imaging assessment and the feasibility of sampling. [2], [5]
Treatment Pathway After Breast Tissue Diagnosis
Breast biopsy results determine subsequent management through standard breast care pathways. [2]
Initiation Thresholds and Likelihood Ranges
BI-RADS 4A corresponds to a malignancy likelihood range of more than 2% to 10% (low suspicion). [4]
Common Pitfalls to Avoid
Over-referral to unrelated specialties delays breast-directed diagnostic sampling when tissue diagnosis is indicated. [2], [5]
Practical Specialty Coordination
Breast radiology and/or a breast intervention program performs the diagnostic sampling that follows a BI-RADS 4A assessment. [2], [5]
Target Goals of Evaluation
The evaluation goal is obtaining diagnostic tissue to confirm or exclude malignancy and to guide definitive breast management. [2], [5]